4
Shared Docs
4
Same-Page
4 / 4
Mentions
HEART x 2 (#2): Myocardial and perivascular fibrosis. Slightly hypertrophied myocytes. LUNG x 5 (#3,4): Slight patchy emphysema. LIVER x 1 (#1): Steatosis involving approximately 50% of hepatic parenchyma. Slight periportal fibrosis. Marked congestion. KIDNEY x 1 (#1): Arteriolar sclerosis. Congestion
ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5
6 HEART x 2 (#2): Myocardial and perivascular fibrosis. Slightly hypertrophied myocytes. LUNG x 5 (#3,4): Slight patchy emphysema. LIVER x 1 (#1): Steatosis involving approximately 50% of hepatic parenchyma. Slight periportal fibrosis. Marked congestion. KIDNEY x 1 (#1): Arteriolar sclerosis. Congestion
thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P
HEART x 2 (#2): Myocardial and perivascular fibrosis. Slightly hypertrophied myocytes. LUNG x 5 (#3,4): Slight patchy emphysema. LIVER x 1 (#1): Steatosis involving approximately 50% of hepatic parenchyma. Slight periportal fibrosis. Marked congestion. KIDNEY x 1 (#1): Arteriolar sclerosis. Congestion
ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m
HEART x 2 (#2): Myocardial and perivascular fibrosis. Slightly hypertrophied myocytes. LUNG x 5 (#3,4): Slight patchy emphysema. LIVER x 1 (#1): Steatosis involving approximately 50% of hepatic parenchyma. Slight periportal fibrosis. Marked congestion. KIDNEY x 1 (#1): Arteriolar sclerosis. Congestion
ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL
Entities connected to both Steatosis and LC-MS

Jeffrey Epstein
PERSON
Ghislaine Maxwell
PERSONNEUROPATHOLOGY
ORGANIZATIONSpecial Housing Unit
ORGANIZATIONNA-FUBIC
ORGANIZATIONAMB-CHMINACA
ORGANIZATIONNew York Office of Chief Medical
ORGANIZATIONPositive
LOCATIONVentricles
PERSONBarbara A. Sampson
PERSONHippocampi
PERSONFUBINACA
ORGANIZATIONNew York Criminal Procedure Law Section 190.30(2
ORGANIZATIONAMB-FUBINACA
ORGANIZATION
Metropolitan Correctional Center
ORGANIZATIONMD-Ph.D.
ORGANIZATIONNYPD Phone
ORGANIZATIONPCLAS
ORGANIZATIONNMS Labs
ORGANIZATIONHorsham
LOCATION